ENTITY
Jiangsu Hengrui Medicine

Jiangsu Hengrui Medicine (600276 CH)

490
Analysis
Health Care • China
Jiangsu Hengrui Medicine Co., Ltd. develops, manufactures, and markets a variety of medicines and medicine packing materials. The Company's products include anti-tumor medicines, pain-killers, anti-infection medicines, aluminum foil, and other related products.
more
bullish•Quantitative Analysis
•03 May 2020 17:18

SH/​SZ Connect Flow Weekly: Active Flows for Vaccine Stocks

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to highlight key stocks and sectors which the mainland investors traded via the...

Logo
359 Views
Share
bearish•Quantitative Analysis
•23 Mar 2020 14:52

SH/SZ Connect Flows: Hikvision, Mindray, Moutai, Hengrui

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...

Logo
438 Views
Share
bullish•Quantitative Analysis
•17 Dec 2019 17:32

Shanghai/​​​Shenzhen Connect Flows: $3bn Inflows Ahead of Phase 1 Trade Deal

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...

Logo
548 Views
Share
bullish•Kweichow Moutai
•16 Sep 2019 11:38

Shanghai/​​Shenzhen Connect Ideas: Pre-Mid Autumn Hard Liquor Outflows (2019-09-13)

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...

Logo
488 Views
Share
•21 Aug 2019 02:46

Shanghai Henlius Biotech IPO Initiation: Going Large

Shanghai Henlius Biotech (1566213D HK) is a biopharmaceutical company and a non-wholly owned subsidiary of Shanghai Fosun Pharmaceutical (Group)...

Logo
891 Views
Share
x